miR-127 protects proximal tubule cells against ischemia/reperfusion : identification of Kinesin family member 3B as miR-127 target [[Elektronische Ressource]]
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS One, volume 7, issue 9, e44305 (2012)
- Schlagwort
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Univ.-Bibliothek Frankfurt am Main
- (wann)
-
2012
- Beteiligte Personen und Organisationen
-
Aguado-Fraile, Elia
Ramos, Edurne
Sáenz-Morales, David
Conde, Elisa
Blanco-Sánchez, Ignacio
Stamatakis, Konstantinos
Peso, Luis del
Cuppen, Edwin
Brüne, Bernhard
García Bermejo, María Laura
- URN
-
urn:nbn:de:hebis:30:3-263414
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aguado-Fraile, Elia
- Ramos, Edurne
- Sáenz-Morales, David
- Conde, Elisa
- Blanco-Sánchez, Ignacio
- Stamatakis, Konstantinos
- Peso, Luis del
- Cuppen, Edwin
- Brüne, Bernhard
- García Bermejo, María Laura
- Univ.-Bibliothek Frankfurt am Main
Entstanden
- 2012
Ähnliche Objekte (12)
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms